Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative •...

44
Best option in main stem and multivessel disease CABG, PCI or medical therapy Franz-Josef Neumann

Transcript of Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative •...

Page 1: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Best option in main stem and multivessel disease

CABG, PCI or medical therapy

Franz-Josef Neumann

Page 2: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Revascularisation vs conservative therapy

PCI vs CABG – The SYNTAX trial

Role of anatomic complexity

Role of left main involvement

Best option in main stem and multivessel disease

CABG, PCI or medical therapy

Page 3: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Revascularisation vs conservative therapy

PCI vs CABG – The SYNTAX trial

Role of anatomic complexity

Role of left main involvement

Best option in main stem and multivessel disease

CABG, PCI or medical therapy

Page 4: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

CABG Superior to Conservative

• Left main disease

• Triple- or double-vessel disease involving the proximal LAD

• Triple- or double-vessel disease in the presence of severe

angina or large areas of ischemia on functional testing

• Triple-vessel disease associated with impaired LV-function

Page 5: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

PCI equal to CABG?

• Left main disease

• Triple- or double-vessel disease involving the proximal LAD

• Triple- or double-vessel disease in the presence of severe

angina or large areas of ischemia on functional testing

• Triple-vessel disease associated with impaired LV-function

CABG Superior to Conservative

Page 6: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Hannan EL et al., Circulation 2006

Lower Adjusted Mortality with CABG vs. DES

Page 7: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Hannan EL et al., Circulation 2006

Lower Mortality with Complete Revascularisation

Complete revascularisation

Incomplete revascularisation

no chronic total occlusion

only one chronic total occlusion

chronic total occlusion + other lesion

0 2 4 6 8 10 12

8.6

10.5

11.2

11.3

3-year mortality (%)

P < 0.03

Page 8: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Who benefits from elective PCI?

Page 9: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Boden WE et al., N Engl J Med 2007

18.5 19

0

5

10

15

20

Incidence of death & MI (%)

Conservative PCI

PCI Superior to Conservative?

Page 10: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Shift in Paradigm:

From angiographic to functional guidance for PCI

FAME: Tonino PA et al., N Engl J Med 2009

Functional guidance (FFR)

Angiographic guidance

11.1

7.3

Death & MI

18.3

13.2

0

5

10

15

20

1-year incidence (%)

MACE

P = 0.02

P = 0.04

Page 11: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

FAME II: De Bruyne B et al., N Engl J Med 2012

3.0

FFR-guided

conservative

0

5

10

15

1-year incidence of death, MI & urgent TVR(%)

4.3

FFR-guided

PCI

Shift in Paradigm:

From angiographic to functional guidance for PCI

12.7

Conservative

despite FFR < 0.8

P < 0.001n.s.

Page 12: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

FAME II: De Bruyne B et al., N Engl J Med 2012

1.8

FFR-guided

conservative

0

5

10

15

1-year incidence of death & MI (%)

3.4

FFR-guided

PCI

Benefit of FFR-guided PCI?

3.9

Conservative

despite FFR < 0.8

n.s.n.s.

Page 13: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Large ischaemic area:

Improved survival with revascularisation

Hachamovitch R et al. Circulation 2003

0

2

4

6

8

10

0% 1-5% 5-10% 11-20% >20%

Mortality (%)

Ischaemic area (% of LV myocardium)

n=10627

Medical

therapy

PCI / CABG

Page 14: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Hachamovitch R et al. Circulation 2003

Cardiac death

Large ischaemic area:

Improved survival with revascularisation

Page 15: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Shaw LJ et al., Circulation 2008

Years to follow-up

Survival without myocardial infarction

Residual ischemic area (% of LV)

Best outcome with revascularisation

and no residual ischaemic area

Page 16: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Revascularisation vs conservative therapy

PCI vs CABG – The SYNTAX trial

Role of anatomic complexity

Role of left main involvement

Best option in main stem and multivessel disease

CABG, PCI or medical therapy

Page 17: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD
Page 18: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

MACCE to 5 Years

TAXUS (N=903)CABG (N=897)

Serruys PW., ESC 2012

Page 19: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Repeat Revascularization to 5 Years

TAXUS (N=903)CABG (N=897)

Serruys PW., ESC 2012

Page 20: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

CVA to 5 Years

TAXUS (N=903)CABG (N=897)

Serruys PW., ESC 2012

Page 21: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Myocardial Infarction to 5 Years

TAXUS (N=903)CABG (N=897)

Serruys PW., ESC 2012

Page 22: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

TAXUS (N=903)CABG (N=897)

All-Cause Death to 5 Years

Serruys PW., ESC 2012

Page 23: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

TAXUS (N=903)CABG (N=897)

Cardiac Death to 5 Years

Serruys PW., ESC 2012

Page 24: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD
Page 25: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

4-year mortality (%)

10

5

0

20Bypass

PCI

8.8%

11.7%

P = 0.05

Losses to follow-up impact on outcome

8.2%

11.5%

P = 0.02

All non-evaluable patients

having survived

Non-evaluable

patients

similar survival as

evaluable patients

1516.9%

14.2%

P = 0.10

All non-evaluable

patients

having died

Page 26: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Revascularisation vs conservative therapy

PCI vs CABG – The SYNTAX trial

Role of anatomic complexity

Role of left main involvement

Best option in main stem and multivessel disease

CABG, PCI or medical therapy

Page 27: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Serruys PW., ESC 2012

CABG (n=275)

PCI (n=299)

SYNTAX-Score < 23: Similar MACCE Rate

Page 28: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Bypass PCI

SYNTAX-Score < 23: Similar Outcomes

Serruys PW., ESC 2012

5-year incidence (%)

P = 0.11 P = 0.64 P = 0.11 P = 0.81

20

10

5

0

4.2%

7.8%

10.1%8.9%

Death

4.0%1.8%

Stroke

14.9%

16.1%

DeathMI, stroke

25

15

30

Myocardialinfarction

Page 29: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

SYNTAX-Score 23-32: More MACCE with PCI

Serruys PW., ESC 2012

CABG (n=310)

PCI (n=300)

Page 30: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Bypass PCI

SYNTAX-Score 23-32: More Infarctions with PCI

Serruys PW., ESC 2012

5-year incidence (%)

P < 0.001 P = 0.68 P = 0.25 P = 0.42

20

10

5

03.6%

11.2%12.7%

13.8%

Death

3.6%2.0%

Stroke

18.0%

20.7%

DeathMI, stroke

25

15

30

Myocardialinfarction

Page 31: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

SYNTAX-Score >32: More MACCE with PCI

Serruys PW., ESC 2012

CABG (n=315)

PCI (n=290)

Page 32: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Bypass PCI

4-year incidence (%)

P = 0.004 P = 0.005 P = 0.80 P = 0.007

20

10

5

03.9%

10.1%

Myocardialinfarction

11.4%

19.2%

Death

3.7% 3.5%

Stroke

17.1%

26.1%

DeathMI, stroke

25

15

SYNTAX-Score >32: More Deaths with PCI

Serruys PW., ESC 2012

30

Page 33: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Revascularisation vs conservative therapy

PCI vs CABG – The SYNTAX trial

Role of anatomic complexity

Role of left main involvement

Best option in main stem and multivessel disease

CABG, PCI or medical therapy

Page 34: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Bypass PCI

5-year MACCE (%)

50

20

30

10

0

31.5% 30.4%

P = 0.74

5-year mortality (%)

P = 0.11

15

10

5

0

26.8%

33.3%

P = 0.21

11.3%

7.0%

P = 0.28

20 40

3 vesselLeft main 3 vesselLeft main

9.3%10.2%

25

SYNTAX-Score < 23: Left main and 3-vd similar

Kappetein AP, TCT 2012

Page 35: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

SYNTAX-Score > 32: Left main and 3-vd similar

5-year MACCE (%)

50

20

30

10

0

29.7%

46.5%

P = 0.003

5-year mortality (%)

14.1%

20.9%

P = 0.11

15

10

5

0

24.1%

41.9%

P < 0.001

8.8%

17.8%

P = 0.02

20 40

3 vesselLeft main

Bypass PCI

3 vesselLeft main

25

Kappetein AP, TCT 2012

Page 36: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

SYNTAX-Score 23-32 : Left main and 3-vd different?

Bypass PCI

5-year MACCE (%)

50

20

30

10

0

32.7% 32.3%

P = 0.88

5-year mortality (%)

P = 0.040

15

10

5

0

22.6%

37.9%

P < 0.001

19.3%

8.9%

P = 0.047

20 40

3 vesselLeft main 3 vesselLeft main

9.6%

16.3%

25

Kappetein AP, TCT 2012

Page 37: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Leipzig Multicenter Left Main:

Similar Death & Infarction

Boudriot E et al., J Am Coll Cardiol 2011

Page 38: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Leipzig Left Main:

No significant increase in MACE

Boudriot E et al., J Am Coll Cardiol 2011

n = 100

n = 101

Page 39: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

PRECOMBAT:

Similar death, infarction and stroke

Park SJ et al., N Engl J Med 2011

Page 40: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

PRECOMBAT:

No significant increase in MACCE

Park SJ et al., N Engl J Med 2011

Page 41: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

No difference in 5-year survival after PCI vs. CAGB

- MAIN-COMPARE -

Park DW et al., J Am Coll Cardiol 2010

Adjusted hazard ratio:

1.00 (0.73–1.37)

P=0.99

N = 1,474

DES

CABG

Page 42: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Differential outcome according to SYNTAX score

Park DW et al., J Am Coll Cardiol 2011

0.2 0.5 1 2 5 10 50PCI better CABG better

Adjusted Hazard Ratio

Death

Death, MI, stroke

Reintervention

SYNTAX score

< 23

23 – 32

> 32

Page 43: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

Distal left main?

SYNTAX-Score

Proximal left main 12

Bifurcation 18Medina 1/1/1

> 20 mm

Severe calcification

left dominance

Trifurcation 21All branches involved

> 20 mm

Severe calcification

left dominance

Page 44: Best optionin mainstemandmultivesseldisease CABG, PCI ... Neumann...CABG Superior toConservative • Left main disease • Triple- or double-vessel disease involving the proximal LAD

SYNTAX-Score 23 – 32 Heart team

SYNTAX-Score > 32 CABG

SYNTAX-Score < 23 PCI

Best option in main stem and multivessel disease

CABG, PCI or medical therapy